Jason Zemansky
Stock Analyst at B of A Securities
(4.74)
# 150
Out of 4,734 analysts
33
Total ratings
70.83%
Success rate
24.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Zemansky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KURA Kura Oncology | Maintains: Buy | $36 → $29 | $7.39 | +292.42% | 2 | Nov 22, 2024 | |
| INSM Insmed | Maintains: Buy | $84 → $86 | $76.75 | +12.05% | 8 | Oct 9, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $30 → $31 | $13.67 | +126.77% | 3 | Aug 15, 2024 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $24 → $23 | $14.14 | +62.66% | 4 | Aug 9, 2024 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | $2.9 → $2.5 | $2.15 | +16.28% | 5 | Jun 20, 2024 | |
| CYTK Cytokinetics | Maintains: Neutral | $70 → $60 | $45.82 | +30.95% | 3 | May 23, 2024 | |
| ALVR AlloVir | Downgrades: Underperform | $17 → $1 | $9.38 | -89.34% | 2 | Dec 26, 2023 | |
| HOWL Werewolf Therapeutics | Maintains: Buy | $9 → $10 | $1.36 | +635.29% | 4 | May 12, 2023 | |
| ALLK Allakos | Maintains: Buy | $145 → $155 | $1.11 | +13,863.96% | 2 | Dec 13, 2021 |
Kura Oncology
Nov 22, 2024
Maintains: Buy
Price Target: $36 → $29
Current: $7.39
Upside: +292.42%
Insmed
Oct 9, 2024
Maintains: Buy
Price Target: $84 → $86
Current: $76.75
Upside: +12.05%
Syndax Pharmaceuticals
Aug 15, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $13.67
Upside: +126.77%
Arcus Biosciences
Aug 9, 2024
Maintains: Neutral
Price Target: $24 → $23
Current: $14.14
Upside: +62.66%
Esperion Therapeutics
Jun 20, 2024
Downgrades: Underperform
Price Target: $2.9 → $2.5
Current: $2.15
Upside: +16.28%
Cytokinetics
May 23, 2024
Maintains: Neutral
Price Target: $70 → $60
Current: $45.82
Upside: +30.95%
AlloVir
Dec 26, 2023
Downgrades: Underperform
Price Target: $17 → $1
Current: $9.38
Upside: -89.34%
Werewolf Therapeutics
May 12, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.36
Upside: +635.29%
Allakos
Dec 13, 2021
Maintains: Buy
Price Target: $145 → $155
Current: $1.11
Upside: +13,863.96%